Sonja Nelson

Track

Insider profile

Currently holds a position at Immunitybio Inc

Positions

Position Company Period
Chief Financial Officer Immunitybio Inc June 11, 2018 -
Chief Accounting Officer Immunitybio Inc May 1, 2016 - June 1, 2018
Sonja Nelson's trades of Ambrx Biopharma Cayman Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
447.95
Quantity 86,857
Value US$71,547
Transaction date
Planned sale
Price
241.97
Quantity 82,627 -16.6%
Value US$4,549,902
Transaction date
Planned sale
Price
13.62
Quantity 39,271 -65.8%
Value US$534,938
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-10-31 2023-10-27
PlS Planned sale
81,705 -47.0%
95.03
US$803,224 		81,705 -47.0% 95.03 US$803,224
2023-10-27 2023-10-27
PrS Proposed sale
86,857
447.95
US$71,547 		86,857 447.95 US$71,547
2021-01-13 2021-01-12
PlS Planned sale
82,627 -16.6%
241.97
US$4,549,902 		82,627 -16.6% 241.97 US$4,549,902
2021-01-06 2021-01-04
PlS Planned sale
39,271 -65.8%
13.62
US$534,938 		39,271 -65.8% 13.62 US$534,938